|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 14, 2022 08:28PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 07:49PM
|
|
Re: Research Reports Initiated: just their nr and link...
|
1
|
Resverlogix Corp.
|
Dec 06, 2016 08:44PM
|
|
Re: Hepalink
|
1
|
Resverlogix Corp.
|
Jun 13, 2022 01:50PM
|
|
Re: Option #2 and Option #3 questions
|
1
|
Resverlogix Corp.
|
Oct 27, 2020 02:41PM
|
|
Re: Option #2 and Option #3 questions
|
1
|
Resverlogix Corp.
|
Oct 27, 2020 03:41PM
|
|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 17, 2017 09:52AM
|
|
RESVERLOGIX CORP. Annual And Special Meeting: December 22, 2020
|
2
|
Resverlogix Corp.
|
Nov 25, 2020 07:57AM
|
|
Re: A Special Meeting of Shareholders?
|
2
|
Resverlogix Corp.
|
May 31, 2024 10:45AM
|
|
Re: A few things
|
2
|
Resverlogix Corp.
|
Oct 17, 2017 11:22AM
|
|
Re: Looking forward now , can/will management use this meeting as the start of many positive updates?
|
2
|
Resverlogix Corp.
|
Aug 30, 2022 03:30PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
2
|
Resverlogix Corp.
|
Sep 14, 2017 11:02AM
|
|
Re: 2 year extension
|
2
|
Resverlogix Corp.
|
May 14, 2024 12:14PM
|
|
Re: Trials and statistics, next steps
|
2
|
Resverlogix Corp.
|
Feb 11, 2020 07:31PM
|
|
Re: Forward looking statements...
|
2
|
Resverlogix Corp.
|
Feb 05, 2021 11:31AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
2
|
Resverlogix Corp.
|
Apr 14, 2021 11:22PM
|
|
Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
2
|
Resverlogix Corp.
|
Jun 05, 2017 07:35AM
|
|
Re: Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Jun 21, 2023 08:37AM
|
|
Re: Violation Report
|
2
|
Resverlogix Corp.
|
Nov 27, 2020 01:27PM
|
|
Re: Outfits like ActiveWallStreet....... rec'd
|
2
|
Resverlogix Corp.
|
Dec 07, 2016 08:02PM
|
